Diabetic ketoacidosis
Artículo
Open/ Download
Access note
Acceso Abierto
Publication date
2020
Abstract
Diabetic ketoacidosis (DKA) is the most common acute hyperglycaemic emergency in people with diabetes mellitus. A diagnosis of DKA is confirmed when all of the three criteria are present - 'D', either elevated blood glucose levels or a family history of diabetes mellitus; 'K', the presence of high urinary or blood ketoacids; and 'A', a high anion gap metabolic acidosis. Early diagnosis and management are paramount to improve patient outcomes. The mainstays of treatment include restoration of circulating volume, insulin therapy, electrolyte replacement and treatment of any underlying precipitating event. Without optimal treatment, DKA remains a condition with appreciable, although largely preventable, morbidity and mortality. In this Primer, we discuss the epidemiology, pathogenesis, risk factors and diagnosis of DKA and provide practical recommendations for the management of DKA in adults and children.
Patrocinador
merican Diabetes Association 1-17-IBS-186
United States Department of Health & Human Services
National Institutes of Health (NIH) - USA
NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) U34DK123894
Fondo Nacional de Ciencia y Tecnologia (FONDECYT) from the Government of Chile 1170895
National Center for Advancing Translational Sciences of the National Institutes of Health (NIH) from the Clinical and Translational Science Award program UL1TR002378
United States Department of Health & Human Services
National Institutes of Health (NIH) - USA U30
P30DK11102
Dexcom
Novo Nordisk
Sanofi
Indexation
Artículo de publicación ISI Artículo de publicación SCOPUS
Quote Item
Nature Reviews Disease Primers Volume 6 Issue1 (2020)
Collections
The following license files are associated with this item: